The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...

CVRx, Inc. a developer of neuromodulation solutions for patients with cardiovascular diseases, announced initiation of the ...

Prescription neuromodulation can be administered outside the clinic with physician oversig ...

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant ...

Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.

The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed ...

Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...

The Company also announced that Frank Fischer, founder and chairman of the board of Neuropace and medtech serial entrepreneur, recently joined the Juniper Board of Directors.